Author:
Allam Nader,Jeffrey Zabel W.,Demidov Valentin,Jones Blake,Flueraru Costel,Taylor Edward,Alex Vitkin I.
Abstract
AbstractStereotactic body radiotherapy (SBRT) is an emerging cancer treatment due to its logistical and potential therapeutic benefits as compared to conventional radiotherapy. However, its mechanism of action is yet to be fully understood, likely involving the ablation of tumour microvasculature by higher doses per fraction used in SBRT. In this study, we hypothesized that longitudinal imaging and quantification of the vascular architecture may elucidate the relationship between the microvasculature and tumour response kinetics. Pancreatic human tumour xenografts were thus irradiated with single doses of $$10$$
10
, $$20$$
20
and $$30$$
30
Gy to simulate the first fraction of a SBRT protocol. Tumour microvascular changes were monitored with optical coherence angiography for up to $$8$$
8
weeks following irradiation. The temporal kinetics of two microvascular architectural metrics were studied as a function of time and dose: the diffusion-limited fraction, representing poorly vascularized tissue $$>150$$
>
150
μm from the nearest detected vessel, and the vascular distribution convexity index, a measure of vessel aggregation at short distances. These biological metrics allowed for dose dependent temporal evaluation of tissue (re)vascularization and vessel aggregation after radiotherapy, showing promise for determining the SBRT dose–response relationship.
Funder
Natural Sciences and Engineering Research Council of Canada
Ontario Graduate Scholarship
Princess Margaret Cancer Foundation
Terry Fox Foundation’s Strategic Training in Transdisciplinary Radiation Sciences for the 21st Century
Canadian Institutes of Health Research
Publisher
Springer Science and Business Media LLC
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献